We previously showed that PMA-mediated PKC activation and activation of the MAPK/ERK1/2 pathway contributes to increased proliferation and reduced apoptosis of melanoma cells under anchorage-deprived conditions. This evidence concerns the gene MAPK3 and melanoma.